Table 1.
Summary of T. haneyi nested PCR (nPCR) and equine β-actin PCR results during treatment (Tx) with BPQ
| Weeks post-Tx | HO-270 | HO-364 | HO-776 | HO-777 | HO-784 | HO-411 | HO-413 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | T. haneyi nPCR | β-Actin PCR | |
| 0a | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| 1 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 2 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 3 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 4 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 5 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 6 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 7 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 8 | − | + | − | + | + | + | + | + | + | + | + | + | + | + |
| 9 | − | + | + | + | + | + | + | + | − | + | + | + | + | + |
| 10 | − | + | + | + | − | + | − | + | + | + | + | + | + | + |
| 11 | − | + | − | + | + | + | − | + | + | + | + | + | + | + |
| 12 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 13 | − | + | − | + | − | + | + | + | + | + | + | + | + | + |
| 14 | + | + | − | + | + | + | + | + | + | + | + | + | + | + |
| 15 | − | + | + | + | + | + | − | + | − | + | + | + | + | + |
| 16 | − | + | + | + | + | + | + | + | + | + | + | + | + | + |
| 17 | + | + | + | + | − | + | − | + | + | + | + | + | + | + |
| 18a | − | + | + | + | − | + | − | + | − | + | + | + | + | + |
| 19b | − | + | + | + | + | + | − | + | + | + | + | + | + | + |
| 20 | − | + | − | + | − | + | − | + | + | + | + | + | + | + |
| 21 | − | + | + | + | − | + | − | + | + | + | nt | nt | nt | nt |
| 22 | − | + | + | + | − | + | − | + | + | + | nt | nt | nt | nt |
| 23 | − | + | − | + | + | + | + | + | − | + | + | + | + | + |
| 24 | + | + | + | + | + | + | + | + | − | + | nt | nt | nt | nt |
| 25 | − | + | + | + | − | + | + | + | + | + | nt | nt | nt | nt |
| 26 | − | + | + | + | − | + | − | + | − | + | nt | nt | nt | nt |
| 27 | − | + | − | + | − | + | − | + | − | + | + | + | + | + |
| 28 | − | + | + | + | − | + | − | + | + | + | nt | nt | nt | nt |
| 29 | − | + | + | + | − | + | − | + | + | + | nt | nt | nt | nt |
| 30 | − | + | + | + | − | + | + | + | + | + | nt | nt | nt | nt |
| 31 | − | + | − | + | + | + | − | + | + | + | + | + | nt | nt |
| 32 | − | + | + | + | − | + | + | + | + | + | nt | nt | nt | nt |
| 33 | − | + | − | + | + | + | + | + | + | + | nt | nt | nt | nt |
| 34 | spl | nt | nt | nt | spl | nt | nt | nt | nt | nt | nt | nt | nt | nt |
| 35 | + | nt | nt | nt | + | nt | nt | nt | nt | nt | nt | nt | nt | nt |
spl splenectomy, nt not tested
aRepresents the time of treatment at 0 and 18 weeks
bRepresents treatment of HO-784 at 19 weeks post-treatment with 6 mg/kg of BPQ